Nataliia D. Lantukhova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nataliia D. Lantukhova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bitchuk
Kharkiv National Medical University
1 shared publication - Mariia Yuriivna Koteliukh
Kharkiv National Medical University, Kharkiv, Ukraine
1 shared publication - Nadiia Demikhova
Sumy State University, Sumy, Ukraine; Tallinn University of Technology, Tallinn, Estonia
1 shared publication - Nataliia Makieieva
Kharkiv National Medical University
1 shared publication - Svitlana Bokova
Sumy State University
1 shared publication - V. V. Andrushchenko
Kharkiv National Medical University
1 shared publication
Latest Publications
- 1 May 2026
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini
- Vol. 2026 (2) , 150-157
Developing the «Paramedic» Educational and Professional Program in Ukraine’s Higher Medical Education as a Response to Security Challenges
Background. The armed conflict in Ukraine, which has been ongoing for more than 12 years, has fundamentally changed the structure of emergency medical care. The pre-hospital stage has become a critically important link that directly affects preventable mortality rates among both the civilian population and military personnel. Aim. To examine the importance of developing professional knowledge and practical skills among emergency medical services personnel in both wartime and peacetime. To present the results of the design and development of the «Paramedic» curriculum for training emergency medical services professionals in Ukraine. Materials and Methods. A content analysis of contemporary scientific sources and guidelines from the Ministry of Health of Ukraine, as well as materials from initiatives such as Global Health Engagement (GHE) covering the period 2016–2026 was conducted. Results. This study examines the «Paramedic» professional qualification category — a new one for Ukrainian medicine — in the context of healthcare and medical education reform. An educational program titled «Paramedic» has been developed and structured as a component of the educational process at Kharkiv National Medical University. Conclusions. Paramedicine is a new type of healthcare service, and its implementation represents an important stage in the development of medicine in any country.
- 1 May 2026
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini
- Vol. 2026 (2) , 150-157
Developing the «Paramedic» Educational and Professional Program in Ukraine’s Higher Medical Education as a Response to Security Challenges
Background. The armed conflict in Ukraine, which has been ongoing for more than 12 years, has fundamentally changed the structure of emergency medical care. The pre-hospital stage has become a critically important link that directly affects preventable mortality rates among both the civilian population and military personnel. Aim. To examine the importance of developing professional knowledge and practical skills among emergency medical services personnel in both wartime and peacetime. To present the results of the design and development of the «Paramedic» curriculum for training emergency medical services professionals in Ukraine. Materials and Methods. A content analysis of contemporary scientific sources and guidelines from the Ministry of Health of Ukraine, as well as materials from initiatives such as Global Health Engagement (GHE) covering the period 2016–2026 was conducted. Results. This study examines the «Paramedic» professional qualification category — a new one for Ukrainian medicine — in the context of healthcare and medical education reform. An educational program titled «Paramedic» has been developed and structured as a component of the educational process at Kharkiv National Medical University. Conclusions. Paramedicine is a new type of healthcare service, and its implementation represents an important stage in the development of medicine in any country.
- Open Access
- 17 April 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 2,p. 105-111
A PREDICTION MODEL FOR CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Introduction. One of the common adverse complications that may occur in patients with type 2 diabetes mellitus (T2DM) after acute myocardial infarction (AMI) is the development and progression of chronic heart failure (CHF). Currently, it remains relevant to study biomarkers of energy homeostasis that are involved in the pathogenesis of CHF in T2DM patients. Aim. To predict the development of CHF in patients with T2DM using a generalized linear mixed model (GLMM). Materials and methods. A total of 74 patients with T2DM were examined after ST-segment elevation AMI (STEMI). Serum concentrations of adropin, fatty acid binding protein 4 (FABP4) and C1q/TNF-related protein 3 (CTRP3) were measured using enzyme-linked immunosorbent assays. Fasting blood glucose levels were determined by the glucose oxidase method. Serum high-density lipoprotein (HDL) levels were analyzed by the peroxidase enzymatic method. Low-density lipoprotein (LDL) levels were estimated by the Friedewald formula. The GLMM was applied to construct a predictive model of CHF in patients with T2DM. Results. The study has revealed decreased serum adropin and CTRP3 levels and increased FABP4 levels in T2DM patients after STEMI. A predictive model of CHF development in patients with T2DM has been developed. The fixed effects of the model were represented by two univariate (adropin and CTRP3 on day 1) and two bivariate indicators (adropin and FABP4 on day 10, glucose on day 1 and 10), as well as the random effects were represented by five univariate indicators (acute heart failure, diastolic blood pressure on day 1, heart rate on day 10, LDL on day 1 and HDL on day 1). The accuracy of predicting the occurrence of NYHA functional class II within a year in patients with T2DM was 61.5%, while that of NYHA functional class III was 89.6%. The overall accuracy of the model was 79.7%. Conclusions. Thus, the level of adropin on day 1 has been found to be a strong negative prognostic factor, while the combined effect of the adropin and FABP4 levels on day 10 – a positive prognostic factor. The combined effect of blood glucose levels on day 1 and 10, as well as a negative effect of CTRP3 concentration on day 1 has been shown. The option of using energy metabolism biomarkers in the model has indicated the importance of studying these parameters in T2DM patients.
- 17 April 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 2,p. 105-111
Open AccessA PREDICTION MODEL FOR CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Introduction. One of the common adverse complications that may occur in patients with type 2 diabetes mellitus (T2DM) after acute myocardial infarction (AMI) is the development and progression of chronic heart failure (CHF). Currently, it remains relevant to study biomarkers of energy homeostasis that are involved in the pathogenesis of CHF in T2DM patients. Aim. To predict the development of CHF in patients with T2DM using a generalized linear mixed model (GLMM). Materials and methods. A total of 74 patients with T2DM were examined after ST-segment elevation AMI (STEMI). Serum concentrations of adropin, fatty acid binding protein 4 (FABP4) and C1q/TNF-related protein 3 (CTRP3) were measured using enzyme-linked immunosorbent assays. Fasting blood glucose levels were determined by the glucose oxidase method. Serum high-density lipoprotein (HDL) levels were analyzed by the peroxidase enzymatic method. Low-density lipoprotein (LDL) levels were estimated by the Friedewald formula. The GLMM was applied to construct a predictive model of CHF in patients with T2DM. Results. The study has revealed decreased serum adropin and CTRP3 levels and increased FABP4 levels in T2DM patients after STEMI. A predictive model of CHF development in patients with T2DM has been developed. The fixed effects of the model were represented by two univariate (adropin and CTRP3 on day 1) and two bivariate indicators (adropin and FABP4 on day 10, glucose on day 1 and 10), as well as the random effects were represented by five univariate indicators (acute heart failure, diastolic blood pressure on day 1, heart rate on day 10, LDL on day 1 and HDL on day 1). The accuracy of predicting the occurrence of NYHA functional class II within a year in patients with T2DM was 61.5%, while that of NYHA functional class III was 89.6%. The overall accuracy of the model was 79.7%. Conclusions. Thus, the level of adropin on day 1 has been found to be a strong negative prognostic factor, while the combined effect of the adropin and FABP4 levels on day 10 – a positive prognostic factor. The combined effect of blood glucose levels on day 1 and 10, as well as a negative effect of CTRP3 concentration on day 1 has been shown. The option of using energy metabolism biomarkers in the model has indicated the importance of studying these parameters in T2DM patients.